Speech-Language Pathologists in Oklahoma - Medicare Status, Address, Contact

2326 Speech-Language Pathologists found. Showing 81 - 100

Heather Jarvis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-495-1491

Mrs. Danielle Gulley, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866

Laura Jana Klier, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-438-3834

Jamie Hildenbrand, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866    Fax: 405-782-0024

Jennifer Hathorn, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866    Fax: 405-782-0024

Julie Kim Gray, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-470-2326    Fax: 405-438-3834

Heidi Knight Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6808 Nw 35th St, Bethany, OK 73008 Phone: 405-550-2807

Pamela Beard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866    Fax: 405-440-9341

Riley Rachelle Stinson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-438-3834

Jennifer Fontenot Earnheart, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expressway, Bethany, OK 73008 Phone: 405-440-9866    Fax: 405-782-0024

Rebecca Gregory, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-2242    Fax: 405-782-0024

Victoria Showalter, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711

Mrs. Ann Dell Yeakley, M.ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6721 Nw 42nd St, Bethany, OK 73008 Phone: 405-499-4611

Emily Bagwell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-438-3834

Elizabeth Anne Mcgrew, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-440-6750

Mariana Navas Bryant, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-495-1491

Kelly Wedman, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-495-1491

Mrs. Kellyn Raeshel Gregory, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711

Sarah Burton, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-2242    Fax: 405-782-0024

Monica Benear, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711    Fax: 405-495-1491

News Archive

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.

Six clearly distinguishable subtypes of prediabetes identified

All prediabetes is not the same: in people in the preliminary stages of type 2 diabetes, there are six clearly distinguishable subtypes, which differ in the development of the disease, diabetes risk, and the development of secondary diseases.

Questionable health insurance plans cause concern

Officials worry that people with no insurance will be drawn in by questionable health insurance plans. ABC News reports: The "[h]ealth care overhaul is stalled, resulting in a proliferation of plans that don't fully protect people, officials said. Watchdogs worry about two kinds of plans in particular."

Different genres of video games may affect cognitive training

Video games are quickly becoming a hot topic in cognitive training. Many see them as a potential tool to help patients improve their performance and memory, yet little is known about how different types of video games may affect white matter in the brain and cognition.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8
• 9
• 10
• 11
• »